Cell Therapy Market is expected to Hit US$ 48.98 billion by 2033 | Major Companies - Gilead Sciences, Inc., Novartis AG, Vericel Corporation., CO.DON GmbH

DataM Intelligence has unveiled its latest report on the "Cell Therapy Market Size 2026" delivering powerful insights into key trends, future growth opportunities, and evolving market challenges. Designed to empower smarter decision-making, the report equips businesses with the strategic intelligence needed to stay ahead in a competitive landscape. By blending robust qualitative analysis with data-driven quantitative research, DataM Intelligence offers a well-rounded perspective that helps organizations decode complex market dynamics, unlock new avenues for growth, and seize emerging opportunities in an ever-evolving global market.

Unlock Strategic Partnerships in the Growing Cell Therapy Market-Connect with Key Industry Leaders Today: https://www.datamintelligence.com/partner-identification-enquiry/cell-therapy-market?sz

The Cell Therapy Market size reached US$ 7.92 Billion in 2025 and is expected to reach US$ 48.98 billion by 2033, growing at a CAGR of 21.4% during the forecast period 2026-2033.

The Cell Therapy Market refers to the global industry involved in the development, manufacturing, and commercialization of therapies that use living cells to treat, prevent, or cure diseases. These therapies include stem cell, CAR-T, and regenerative treatments targeting cancer, autoimmune disorders, and degenerative conditions. The market encompasses research institutions, biotechnology and pharmaceutical companies, clinical trials, and advanced manufacturing processes. It is driven by rising demand for personalized medicine, technological advancements, and increasing approvals of innovative cell-based therapies worldwide annually expanding.

Download Free Sample Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/cell-therapy-market?sz

Recent Industry Developments: United States

✅ April 2026: Beam Therapeutics advanced its base-edited cell therapy (risto-cel) for sickle cell disease with published Phase 1/2 clinical results in a major medical journal, showing durable efficacy and moving toward a planned regulatory submission by end of 2026.

✅ January 2026: The U.S. FDA granted Breakthrough Therapy Designation to a CAR-T based therapy (NXC-201) for relapsed/refractory AL amyloidosis, accelerating its clinical development pathway and highlighting continued regulatory support for advanced cell therapies in oncology.

✅ January 2026: FDA cleared an Expanded Access Program for RegeneCyte (cord blood-derived cell therapy), enabling patients with Long COVID to access treatment while clinical trials continue, reinforcing the use of cell therapies for post-viral conditions.

Recent Industry Developments: Japan

✅ April 2026: Japan's PMDA aligned with BioCardia on clinical data acceptance for CardiAMP cell therapy in ischemic heart failure, indicating that foreign clinical trial data (from the U.S.) may be sufficient for Japanese market approval.

✅ March 2026: Japan approved world-first stem cell therapies for Parkinson's disease and severe heart failure, using induced pluripotent stem cells (iPSCs), marking a major milestone in regenerative medicine commercialization.

✅ January 2026: Japan advanced its conditional approval framework for regenerative medicine, supporting pricing and reimbursement adjustments for cell-based therapies, reflecting a structured push toward commercialization of advanced therapies.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cell-therapy-market?sz

List of the Key Players in the Cell Therapy Market:

Gilead Sciences, Inc.
Novartis AG
Vericel Corporation.
CO.DON GmbH
Bristol Myers Squibb Company.
IOVANCE Biotherapeutics, Inc.
Dendreon Pharmaceuticals LLC.
Enzyvant Therapeutics GmbH.
CellTrans.
Gamida Cell Inc.

How Does Market Research Work in the Cell Therapy Market?

Market research for the Cell Therapy Market involves systematic data collection and analysis to understand industry trends, customer behavior, and competitive dynamics. It includes primary research such as surveys and interviews, and secondary research from reports, databases, and publications. Analysts evaluate market size, growth drivers, challenges, and opportunities using qualitative and quantitative methods. Insights are validated through expert opinions and forecasting models, enabling businesses to make strategic decisions, identify target segments, and gain a competitive advantage in a rapidly evolving market.

Latest Mergers and Acquisitions of Cell Therapy Market:

✅ April 2026: Gilead Sciences acquires Arcellx (CAR-T Cell Therapy)
➠ Deal value: $7.8 billion
➠ Focus: BCMA-directed CAR-T cell therapy (anito-cel) for multiple myeloma
➠ Details:
Gilead fully acquired Arcellx, converting it into a wholly owned subsidiary. The deal strengthens Gilead's cell therapy pipeline via Kite, especially in blood cancer CAR-T development.

✅ April 2026: Eli Lilly acquires Kelonia Therapeutics (In vivo CAR-T platform)
➠ Deal value: Undisclosed (reported strategic acquisition)
➠ Focus: In vivo CAR-T and gene delivery platform (iGPS® technology)
➠ Details:
Kelonia's technology enables CAR-T cells to be generated inside the patient's body, improving scalability and reducing manufacturing complexity an emerging next-gen cell therapy approach.

✅ April 2026: Galera Therapeutics merges with Obsidian Therapeutics (TIL cell therapy)
➠ Deal value: $350 million (concurrent financing included)
➠ Focus: Engineered TIL (Tumor Infiltrating Lymphocyte) cell therapies
➠ Details:
The all-stock merger combines Galera and Obsidian into a new clinical-stage biotech focused on engineered cell therapies for solid tumors using advanced protein regulation technology.

Segments Covered in the Cell Therapy Market 2026:

By Source: Autologous, Allogenic.

By Cell Type: Stem Cells, Non-Stem Cells.

By Application: Oncology, GIT Conditions, Musculoskeletal Conditions, Immunodeficiency Disorders, Graft-versus-host disease (GVHD), Others.

Regional Analysis of the Cell Therapy Market:

⇥ North America: Leads the market due to advanced infrastructure, strong R&D investments, and early adoption of new technologies.

⇥ Europe: Shows steady growth supported by strict regulations and increasing focus on sustainability initiatives.

⇥ Asia-Pacific: Fastest-growing region driven by rapid industrialization, urbanization, and rising consumer demand in emerging economies.

⇥ Latin America: Experiences moderate growth with expansion in industrial and commercial sectors.

⇥ Middle East & Africa: Gradual market growth supported by increasing investments and improving economic conditions.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=cell-therapy-market

Key Benefits of the Report:

⏩ Comprehensive Market Insights: Gain a deep understanding of market size, trends, and structure.

⏩ Accurate Forecasting: Access reliable future projections to support long-term planning.

⏩ Competitive Analysis: Identify key players, strategies, and positioning in the market.

⏩ Data-Driven Decisions: Make informed business choices backed by verified data.

⏩ Opportunity Identification: Discover emerging trends and untapped growth areas.

⏩ Risk Mitigation: Reduce uncertainties with thorough market evaluation.

⏩ Customer Insights: Understand consumer behavior, preferences, and buying patterns.

⏩ Strategic Planning Support: Align business strategies with market realities.

⏩ Time & Cost Efficiency: Save resources by leveraging ready-to-use research.

⏩ Customization & Expert Validation: Benefit from tailored insights and industry expert analysis.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Cell Therapy Market in 2025?
◆ What is the projected growth rate of the Cell Therapy Market through 2033?
◆ Who are the key players in the Cell Therapy Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Fabian
Email: fabian@datamintelligence.com
Phone USA: +1 877-441-4866
Phone UK: +44 161-870-5507
Website:https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.